Endometriosis is a chronic gynecological condition that affects approximately 6.5 million women of reproductive age in the United States, and it is especially common among people in their 30s and 40s.
SWHR is pleased to welcome Marianne Slight, Director of Product Management at Verily, as the newest member of its Board of Directors.
The SWHR policy brief, "Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions," discusses the state of autoimmune disease research at the federal level.
SWHR was pleased to attend a special screening of the “Below The Belt” documentary. The film was executive produced by former U.S. Secretary of State Hillary Rodham Clinton, former Senator Orrin Hatch, and others.
SWHR will recognize and honor leaders in health care for their contributions to advancing women’s health at its 2023 Annual Awards Gala on Wednesday, April 26, 2023.
Dr. Marie Bernard, NIH Chief Officer for Scientific Workforce Diversity spoke to SWHR Policy Advisory Council members about diversity’s impact on science, the NIH-Wide Strategic Plan for DEIA, COSWD’s recent efforts, and the NIH UNITE Initiative.
To raise awareness about the challenges related to coverage policies, SWHR released the policy brief, "Issues Affecting Health Care Coverage and Access for Women with Autoimmune Diseases and Conditions." The brief is the first in a series of four.
The winter 2022 SWHR Eye Health Network meeting discussed gender diversity in ophthalmology and challenges for women working in eye health.
The fiscal year (FY) 2023 omnibus spending legislation (H.R. 2617) includes all 12 FY2023 spending bills including resources for advancing women's health.